Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia.
about
Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complexAssociation between genetic variations in prostaglandin E2 receptor subtype EP3 gene (Ptger3) and asthma in the Korean populationTRPA1 agonists evoke coughing in guinea pig and human volunteersInhibition of aldose reductase prevents experimental allergic airway inflammation in mice.Transient receptor potential (TRP) channels in the airway: role in airway disease.Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophagesIncreased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers.The alveolar macrophage: the forgotten cell in asthma.Prostaglandin E(2) produced by the lung augments the effector phase of allergic inflammation.Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykininEvaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.Changing the paradigm for cough: does 'cough hypersensitivity' aid our understanding?The role of cyclooxygenase-2 in the protection against apoptosis in vascular endothelial cells induced by cigarette smoking.Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis.2-(4-{2-[(phenylthio)acetyl]carbonohydrazonoyl}phenoxy)acetamide as a new lead compound for management of allergic rhinitis.Carbon in airway macrophages from children with asthma.The role of transforming growth factor-β1 in airway inflammation of childhood asthma.Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products.Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2.Involvement of PKC, p38 MAPK and AP-2 in IL-1beta-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells.Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.The Value of Induced Sputum in the Diagnosis and Management of Children with Bronchial AsthmaNovel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases.Allergen immunotherapy decreases LPS-induced NF-κB activation in neutrophils from allergic patients.Higher prostaglandin e2 production by dendritic cells from subjects with asthma compared with normal subjects.Resolving a case of split personality.Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients.Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis.Relation between Ocular Comfort, Arachidonic Acid Mediators, and Histamine.Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis.Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis.Profibrotic Effect of IL-9 Overexpression in a Model of Airway RemodelingMacrophage Phagocytosis and Allergen Avoidance in Children With Asthma
P2860
Q24545426-E28E3550-FF26-4B1B-9639-4B5811B5087CQ28221736-C5F66F82-FA31-41E6-B996-EBC8398F6F48Q30491971-3C4BEFBF-93F6-4774-A1C2-2390D2C11CF1Q33490994-FEA73B6F-C05E-4A3B-A78B-CB1C26E09EFDQ33562184-8A4691C3-C5C6-441C-8A03-D6F22AA196D9Q33905199-E6479179-77F9-40CB-B4C0-DD8E6A802DF4Q34206747-2CFFBE4A-66A4-447E-AD68-3DAAEA8FC7DAQ34624136-CF241363-8668-4E3D-BD96-D2E5EF3D9161Q35557412-A26BAB96-F792-465A-9B1B-77A4E98E8ABAQ35811441-E062F32B-E2EB-4E30-A93A-A8EEF8BCEFC2Q35884115-2A9558A1-3570-4C06-B13E-B0CD22ACAF8DQ36246847-E759BE9A-F196-49C3-A281-C6885691EF57Q36270342-2785E84B-F708-4350-938E-5D87D0DFEA1BQ36322131-0115739B-F8C5-4E7E-86FB-8189748B982FQ37418337-54848593-DEE8-413B-8F4C-12E2F5A7564AQ37579268-491E8432-7DE1-4D59-9AA8-90D93A3D6CAEQ37636967-17BC052D-EB85-4466-B274-C1C1ACD5A235Q38005107-6893CFE4-31EE-4640-A33C-F43FB5825613Q38739017-8B0456D0-4C22-4C58-8D39-0B748757DD8DQ38923779-31DE5CAE-A75F-4CBC-A778-0B2AFD662699Q39091858-A3DEAE37-50AD-4F4D-9268-6C8D9B756DD2Q39777516-4B346EF6-1658-4FF0-B207-7FC7DF4AAE4BQ40084084-E016AD18-EB08-4BCD-A3B6-5F01E40CFFB1Q40327781-D7087D0C-6908-4BBA-A281-6DBB4C9E90A4Q41050351-B8900885-5254-4F22-AE70-BA17B2E2584CQ42361937-8932C26E-20C6-4330-957F-9671A6AAF844Q42756883-4FC5FE1B-75D5-47E8-A09D-7F1BBB4E3325Q43690408-A21F7209-3AEB-43B2-A5A5-481DF4AFE845Q44902187-C7C0BC56-06C6-4B51-85FC-B841E0C70EBFQ46448320-DF0106A6-7FA0-4A85-9675-B8C39D7AF720Q46588700-DE0F0176-744A-4053-B7F8-87AF1576EB4AQ46730000-4EE7BDD3-CF17-4DE7-B225-3C05EF5D010CQ46931463-120F5E12-4A57-4799-A289-0EE5B90FE86EQ50922669-21424AC0-E298-4EC6-ABC8-E882B9BBF1F1Q53261571-E226C1D2-2781-4503-BBD2-2C886C6A7C87Q54587415-B6FF5D34-C617-43AA-954B-FB0D200C84BFQ56834648-F82BA536-0EBD-429B-9893-8F70D83D839CQ57092003-E4C07A87-BFCA-45EA-A1E4-262724A20C47
P2860
Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@en
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@nl
type
label
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@en
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@nl
prefLabel
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@en
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@nl
P2093
P50
P1476
Increased prostaglandin E2 con ...... ects with sputum eosinophilia.
@en
P2093
Antonio M Vignola
Franco Mirabella
Giovanni Bonsignore
Mark Gjomarkaj
Rossana Di Giorgi
P304
P356
10.1016/S0091-6749(03)01889-X
P407
P577
2003-10-01T00:00:00Z